Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Definitive treatment of leptomeningeal spinal metastases in children.

Ray GL, Buchsbaum JC, McMullen KP, Simoneaux RV, Hines M, Douglas JG, Johnstone PA.

Pediatr Blood Cancer. 2013 Nov;60(11):1839-41. doi: 10.1002/pbc.24659. Epub 2013 Jun 20.

PMID:
23788317
2.

Pre-Clinical Assessment of Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease.

Ray GL, Baidoo KE, Keller LM, Albert PS, Brechbiel MW, Milenic DE.

Pharmaceuticals (Basel). 2011 Dec 22;5(1):1-15.

3.

Preparation of cystamine core dendrimer and antibody-dendrimer conjugates for MRI angiography.

Nwe K, Milenic DE, Ray GL, Kim YS, Brechbiel MW.

Mol Pharm. 2012 Mar 5;9(3):374-81. doi: 10.1021/mp2003219. Epub 2011 Sep 21.

4.

The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer.

Jaboin JJ, Hwang M, Lopater Z, Chen H, Ray GL, Perez C, Cai Q, Wills ML, Lu B.

Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1330-5. doi: 10.1016/j.ijrobp.2010.01.013. Epub 2010 Jun 3.

5.

Cetuximab: preclinical evaluation of a monoclonal antibody targeting EGFR for radioimmunodiagnostic and radioimmunotherapeutic applications.

Milenic DE, Wong KJ, Baidoo KE, Ray GL, Garmestani K, Williams M, Brechbiel MW.

Cancer Biother Radiopharm. 2008 Oct;23(5):619-31. doi: 10.1089/cbr.2008.0493.

Supplemental Content

Loading ...
Support Center